University Genomics, Inc. is proud to launch its first multianalyte
expression-based diagnostic for breast cancer in
collaboration with ARUP Laboratories. The Breast
Bioclassifier™ is a 55-gene qRT-PCR assay that
classifies ER-positive and ER-negative breast cancers
into expression-based subtypes that more accurately
predict patient outcome. The assay has been validated using fresh frozen and formalin-fixed tissues so
that the test can be offered widely to breast cancer
patients around the world. The Breast Bioclassifier™
provides a read-out of biological subtype and gives
a continuous risk score that enables physicians to
make treatment decisions based on estimates of
survival probabilities given current therapies.